CHU
Poitiers, 86000, France
NCT Number: NCT05144802
The major aim is to evaluate accuracy of 2 Continuous Glucose Monitoring Systems (CGMS) : Dexcom G6® and FreeStyle Libre® in standardized hypoxemia conditions (artificial normobaric hypoxia).
Our purpose is to demonstrate the good performance and calibration of these CGM sensors in hypoxemia conditions.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Poitiers, 86000, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
all population
Inclusion criteria
Patients with diabetes
Inclusion criteria
Healthy volunteers
Non-inclusion criteria : all population
Non-inclusion criteria: Patients with diabetes
Participants will be exposed to a 3-hour acute hypoxia
Time frame: Day 1
The primary endpoint for measuring the accuracy of CGMs (individually) compared to venous blood glucose was the mean absolute relative difference, expressed as a percentage. As the percentages obtained did not follow a normal distribution, they are expressed in the table as median and IQR.
Poitiers University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05018416
Autoimmune Diseases, Chronic Disease
Denver, Colorado, United States
View Trial DetailsNCT00639964
Autoimmune Diseases, Diabetes Mellitus
Lille, France
View Trial DetailsNCT04429503
Autoimmune Diseases, Diabetes Mellitus
Phoenix, Arizona, United States
View Trial DetailsNCT05857007
Autoimmune Diseases, Diabetes Mellitus
Winston-Salem, North Carolina, United States
View Trial Details